1620-1621 / 1778
➢
Retrospectively reported severe late morbidity 5-7% with MRI guided
IGABT. However, mild and moderate are more frequent and may
negatively affect QoL.
➢
EMBRACE prospective analysis confirms ~5% severe late morbidity
➢
QoL analysis provides valuable information on impact of mild morbidity
➢
Most frequently reported symptoms include:
• Bladder: frequency, incontinence
• Rectum: proctitis
• Bowel: diarrea, bowel cramps
• Vaginal: stenosis, dryness
• Other: hot flushes
Summary II